Latest Headlines

Latest Headlines

Genisphere snags $4M to move its 3DNA platform into the clinic

Pennsylvania startup Genisphere locked down a $4 million investment to expand its DNA-based drug delivery platform, looking to finish the preclinical process and license the technology to pharma partners.

GSK obtains rights to inhaled nanoparticles made using Liquidia's PRINT platform

GlaxoSmithKline now has rights to develop inhaled therapeutics using Liquidia's PRINT particle engineering technology. The development builds on a drug delivery alliance between the two companies that commenced in 2012.

Cedars-Sinai team develops delivery-Dx combo nanomed for brain cancer

Researchers in Los Angeles have developed a nanomed that can take on two crucial roles--diagnosing brain tumors and delivering the drugs that can take them down.

'Nanosponges' held in place with a hydrogel absorb toxins in MRSA infections

UCSD researchers have developed a hydrogel that contains toxin-absorbing nanoparticles--what they are calling nanosponges--that could eventually treat skin and wound conditions caused by methicillin-resistant Staphylococcus aureus, or MRSA.

Supercooled nanoparticles offer targeted delivery approach

The ability to supercool drug-carrying vesicles inside the body and time the exact moment of crystallization could lead to a targeted approach to drug delivery, researchers at Tel Aviv University have found.

Nanoparticle coating spurs oral cancer vaccine potential

The stomach and the gut are difficult places for DNA to survive and eventually pass into the bloodstream intact. Now researchers have developed nanoparticle-coated bacteria that can someday be used to create effective DNA vaccines.

Researchers take aim at childhood neuroblastoma with targeted nanoparticles

At the Children's Hospital of Philadelphia, researchers are looking toward biodegradable nanoparticles capable of delivering cancer drugs to neuroblastoma without harming surrounding tissue.

Gold nanoparticles deliver RNA to the brain to suppress cancer genes

Researchers at Northwestern University have put together a nanostructure capable of shuttling a new RNA molecule across the blood-brain barrier to reach tumor cells in mice with glioblastoma multiforme, a particularly aggressive form of brain cancer.

New optogenetics technique does away with genetic modification

The growing field of optogenetics involves the use of light to control neural activity, a process that has wide implications for treating genetic diseases such as macular degeneration. But up until now, the therapy has required the use of genetically modified neurons, limiting its effectiveness in the human population.

MIT team injects drug-carrying hydrogel that 're-heals' in the body

A team of MIT scientists has designed a new injectable hydrogel made from nanoparticles that could someday be used to hold drugs in the body, treating diseases such as cancer, macular degeneration and heart disease.